Demand for safer, non-addictive pain relief options is fueling growth in the chronic lower back pain drugs market. Innovations in neuromodulator drugs and non-opioid analgesics are driving adoption globally. https://www.datamintelligence.com/research-report/chronic-lower-back-pain-drugs-market